Trinity Biotech (TRIB) announced the acquisition of EpiCapture. This acquisition marks Trinity Biotech’s strategic expansion into the oncology diagnostics market. Prostate cancer is the most common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results